Quantum Cyber (QUCY) EBITDA Margin (2022 - 2023)
Quantum Cyber (QUCY) posted EBITDA Margin of 3068.71% for Q4 2023, up 1.17% sequentially from 3104.9% in Q3 2023, and up 127159.0% YoY from N/an in Q4 2022.
Quantum Cyber (QUCY) EBITDA Margin (2022 - 2023) Analysis & Trends
Quantum Cyber has reported EBITDA Margin for 2 years, with the latest figure at 3068.71% in Q4 2023.
- Quarterly EBITDA Margin rose 127159.0% year-over-year to 3068.71% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 2975.47% (up 201513.0% YoY) and the FY2025 annual result came in at 3004.97%, down 90504.0% from the prior year.
- EBITDA Margin rose to 3068.71% in Q4 2023 per QUCY's latest filing, from 3104.9% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2593.94% in Q1 2023 and troughed at 5657.13% in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.99% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -10.07% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 11.58% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 34.98% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 31.97% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 12.10% |
| 10 | Quantum Cyber | 26.42 Mn | 12.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -2,593.94% |
| Dec 31, 2022 | -89,464.86% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -5,599.92% |